NCT05818605View on ClinicalTrials.gov

Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 17, 2023

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions
Hypertrophic Cardiomyopathy
Interventions
BEHAVIORAL

Moderate Intensity Exercise Program

Subjects randomized to the EXER arm will undergo 24 weeks of Moderate Intensity Exercise Training (MIET). Patients will be signed up for 60-minute exercise sessions, 3 times a week

Trial Locations (1)

94143

RECRUITING

University of California - San Francisco, San Francisco

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of California, San Francisco

OTHER